434 - Infection Disease Threats

Bloom and Cadarette Responding to Infectious Disease Threats %20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth %20of%20nations_1.pdf 44. Tacconelli E, Magrini N, Carmeli Y, Harbarth S, Kahlmeter G, Kluytmans J, et al. Global Priority List of Antibiotic-Resistant Bacteria To Guide Research, Discovery, and Development of New Antibiotics . World Health Organization. (2017). Available online at: https://www.who.int/medicines/publications/ global-priority-list-antibiotic-resistant-bacteria/en/ 45. World Health Organization. Multi-Drug Resistant Tuberculosis (MDR-TB): 2017 Update . (2017). Available online at: http://www.who.int/tb/challenges/ mdr/MDR-RR_TB_factsheet_2017.pdf 46. Takahashi H, Keim P, Kaufmann AF, Keys C, Smith KL, Taniguchi K, et al. Bacillus anthracis incident, Kameido, Tokyo, 1993. Emerg Infect Dis. (2004) 10:117–20. doi: 10.3201/eid1001.030238 47. Ramzy A. Japan hangs cult leader for 1995 subway attack. New York Times . (2018). Available online at: https://www.nytimes.com/2018/07/05/ world/asia/japan-cult-execute-sarin.html 48. Shane S. After 8 years, F.B.I. shuts book on anthrax case. New York Times . (2010). Available online at: https://www.nytimes.com/2010/02/20/us/ 20anthrax.html 49. McNeil DG Jr. C.D.C. shuts labs after accidents with pathogens. New York Times . (2014). p. A1. 50. Cello J, Paul AV, Wimmer E. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science. (2002) 297:1016 LP − 8. doi: 10.1126/science.1072266 51. Noyce RS, Lederman S, Evans DH. Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments. PLoS ONE. (2018) 13:e0188453. doi: 10.1371/journal.pone.0188453 52. Kupferschmidt K. How How Canadian researchers reconstituted an extinct poxvirus for $100,000 using mail-order DNA. Science . (2017). doi: 10.1126/science.aan7069. [Epub ahead of print]. 53. End to 10-year British beef ban. BBC News . (2006). Available online at: http:// news.bbc.co.uk/2/hi/4967480.stm 54. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Variant Creutzfeldt-Jakob Disease (vCJD): Risk for Travelers . Centers Dis Control Prev (2018). Available online at: https://www.cdc.gov/prions/vcjd/risk-travelers.html (Accessed December 5, 2018). 55. Bärnighausen T, Bloom DE, Cafiero ET, O’Brien JC. Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil. Semin Immunol. (2013) 25:104–13. doi: 10.1016/j.smim.2013.04.010 56. Bärnighausen T, Bloom DE, Cafiero ET, O’Brien JC. The impact of dengue on tourism in Brazil: an empirical study. Manuscript . (2013). 57. Constenla D, Garcia C, Lefcourt N. Assessing the economics of dengue: results from a systematic review of the literature and expert survey. Pharmacoeconomics. (2015) 33:1107–35. doi: 10.1007/s40273-015- 0294-7 58. Mavalankar DV, Puwar TI, Murtola TM, Vasan SS. Quantifying the Impact of Chikungunya and Dengue on Tourism Revenues . Ahmedabad: Indian Institute of Management (2009). 59. Asiedu E, Jin Y, Kanyama IK. The impact of HIV/AIDS on foreign direct investment: evidence from Sub-Saharan Africa. J African Trade. (2015) 2:1–17. doi: 10.1016/j.joat.2015.01.001 60. Alsan M, Bloom DE, Canning D. The effect of population health on foreign direct investment inflows to low- and middle-income countries. World Dev. (2006) 34:613–30. doi: 10.1016/j.worlddev.2005.09.006 61. Fan VY, Jamison DT, Summers LH. Pandemic risk: how large are the expected losses? Bull World Health Organ. (2018) 96:129–34. doi: 10.2471/BLT.17.199588 62. Burns A, van der Mensbrugghe D, Timmer H. Evaluating the Economic Consequences of Avian Influenza . (Report No. 47417). Washington, DC: The World Bank (2008). 63. Jonas OB. Pandemic Risk . The World Bank. (2013). Available online at: http://siteresources.worldbank.org/EXTNWDR2013/Resources/8258024- 1352909193861/8936935-1356011448215/8986901-1380568255405/ WDR14_bp_Pandemic_Risk_Jonas.pdf 64. The World Bank. World Development Indicators . (2018). Available online at: http://databank.worldbank.org/data/reports.aspx?source=world- development-indicators (Accessed August 24, 2018). 65. Pooran A, Pieterson E, Davids M, Theron G, Dheda K. What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PLoS ONE. (2013) 8:e54587. doi: 10.1371/journal.pone.0054587 66. Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. (2016) 22:416–22. doi: 10.1016/j.cmi.2015.12.002 67. Thorpe KE, Joski P, Johnston KJ. Antibiotic-resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually. Health Aff. (2018) 37:662–9. doi: 10.1377/hlthaff.2017.1153 68. Adeyi OO, Baris E, Jonas OB, Irwin A, Berthe FCJ, Le Gall FG, et al. Drug- Resistant Infections : A Threat to our Economic Future, Vol. 2 : Final Report. Washington, DC: The World Bank (2017). 69. United Nations, Department of Economic and Social Affairs PD. World Urbanization Prospects: The 2018 Revision, Online Edition . New York, NY: Department of Economic and Social Affairs PD. (2018). 70. Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology. (2007) 120:435–46. doi: 10.1111/j.1365-2567.2007.02555.x 71. Ebi KL, Nealon J. Dengue in a changing climate. Environ Res. (2016) 151:115–23. doi: 10.1016/j.envres.2016.07.026 72. Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature. (2007) 447:279–83. doi: 10.1038/nature05775 73. Bonner R. The Rwanda Disaster: The Scene; Cholera Stalks the Rwandan Refugees. New York Times . (1994). p. 00001. 74. Reuters. Yemen Cholera Outbreak Accelerates to 10,000 + Cases Per Week: WHO . Reuters . (2018). Available online at: https://www.reuters.com/ article/us-yemen-security-cholera/yemen-cholera-outbreak-accelerates- to-10000-cases-per-week-who-idUSKCN1MC23J 75. Fox M. “Perfect storm” of conflict threatens Ebola fight in Congo. NBC News . (2018). Available online at: https://www.nbcnews.com/storyline/ ebola-virus-outbreak/perfect-storm-conflict-threatens-ebola-fight-congo- n912856 76. Coutts AP, Fouad FM. Syria’s raging health crisis. New York Times . (2014). Available online at: https://www.nytimes.com/2014/01/02/opinion/syrias- raging-health-crisis.html 77. Laxminarayan R, Matsoso P, Pant S, Brower C, Rottingen J-A, Klugman K, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. (2016) 387:168–75. doi: 10.1016/S0140-6736(15)00474-2 78. Lipsitch M, Galvani AP. Ethical alternatives to experiments with novel potential pandemic pathogens. PLoS Med. (2014) 11:e1001646. doi: 10.1371/journal.pmed.1001646 79. Riedel S. Biological warfare and bioterrorism: a historical review. Proc . (2004) 17:400–6. doi: 10.1080/08998280.2004.11928002 80. Goel AK. Anthrax: a disease of biowarfare and public health importance. World J Clin Cases. (2015) 3:20–33. doi: 10.12998/wjcc.v3.i1.20 81. The National Academies, The U.S. Department of Homeland Security. Biological Attack: Human Pathogens, Biotoxins, and Agricultural Threats . (2004). Available online at: https://www.dhs.gov/sites/default/files/ publications/prep_biological_fact_sheet.pdf 82. Fidler DP. Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. PLoS Med. (2010) 7:e1000247. doi: 10.1371/journal.pmed.1000247 83. Cressey D. Biopiracy ban stirs red-tape fears. Nature. (2014) 514:14–5. doi: 10.1038/514014a 84. Rappuoli R, Black S, Bloom DE, Vaccines and Global Health. In search of a sustainable model for vaccine development and delivery. Manuscript . (2018). 85. Monaco L, Gupta V. The Next Pandemic Will Be Arriving Shortly. Foreign Policy . (2018). Available online at: https://foreignpolicy.com/2018/09/28/ the-next-pandemic-will-be-arriving-shortly-global-health-infectious- avian-flu-ebola-zoonotic-diseases-trump/ 86. Rappuoli R, Bloom DE, Black S. Deploy vaccines to fight superbugs. Nature. (2017) 552:165–7. doi: 10.1038/d41586-017-08323-0 Frontiers in Immunology | www.frontiersin.org 11 March 2019 | Volume 10 | Article 549 FEBRUARY 2020 | T e Surgical Technologist | 71